Drew Spaventa is a serial healthcare founder, operator, and investor. Mr. Spaventa serves on the board of Singular Genomics, a company he founded and led as CEO through 2024, Inflection Medicine, a NICU genetics diagnostics company, and ClicBio, a next-generation weight-loss therapeutics company. He is a Managing Partner at Axon Ventures and a founder of Truvian Sciences. Additionally, Mr. Spaventa was a seed investor and led Corporate Development and Strategy at Edico Genome, which was acquired by Illumina in 2018. He was also a seed investor and part of the founding team for ecoATM, which was acquired by Outerwall (Coinstar) in 2012. Mr. Spaventa received his Master’s degree in Business Administration and Finance from the University of California, San Diego Rady School of Management. He also attended the University of California San Diego, where he obtained his Bachelor’s degree in Political Science and International Relations.